Biotech10 months ago
Sanofi Will Pay 2 Billion for the Biotech Company Inhibrx
With the transaction, Sanofi will assume and repay Inhibrx's outstanding third-party debt and will finance New Inhibrx with $200 million in cash (€183 million) and retain...